These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
463 related items for PubMed ID: 8970587
1. Dysplastic nevi and other risk markers for melanoma. Seykora J, Elder D. Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587 [Abstract] [Full Text] [Related]
2. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi. Schneider JS, Moore DH, Sagebiel RW. Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695 [Abstract] [Full Text] [Related]
3. Melanoma risk in individuals with clinically atypical nevi. Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ. Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717 [Abstract] [Full Text] [Related]
6. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Halpern AC, Guerry D, Elder DE, Clark WH, Synnestvedt M, Norman S, Ayerle R. Arch Dermatol; 1991 Jul; 127(7):995-9. PubMed ID: 2064418 [Abstract] [Full Text] [Related]
7. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. Hansson J, Bergenmar M, Hofer PA, Lundell G, Månsson-Brahme E, Ringborg U, Synnerstad I, Bratel AT, Wennberg AM, Rosdahl I. J Clin Oncol; 2007 Jul 01; 25(19):2819-24. PubMed ID: 17602087 [Abstract] [Full Text] [Related]
8. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T, Swoyer J, Ter-Minassian M, Hedayati M, Grossman L, Goldstein AM, Calista D, Pfeiffer RM. J Natl Cancer Inst; 2005 Jul 06; 97(13):998-1007. PubMed ID: 15998953 [Abstract] [Full Text] [Related]
10. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH. Cancer; 2002 Jun 15; 94(12):3192-209. PubMed ID: 12115352 [Abstract] [Full Text] [Related]
11. Frequency of dysplastic nevi among nevomelanocytic lesions submitted for histopathologic examination. Time trends over a 37-year period. Barnhill RL, Kiryu H, Sober AJ, Mihm MC. Arch Dermatol; 1990 Apr 15; 126(4):463-5. PubMed ID: 2321991 [Abstract] [Full Text] [Related]
12. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. Risser J, Pressley Z, Veledar E, Washington C, Chen SC. J Am Acad Dermatol; 2007 Sep 15; 57(3):428-34. PubMed ID: 17624623 [Abstract] [Full Text] [Related]
16. [Connection between uveal melanoma and dysplastic naevus syndrome]. Hammer H, Tóth-Molnár E, Oláh J, Dobozy A. Magy Onkol; 2005 Apr 15; 49(1):15-8. PubMed ID: 15902328 [Abstract] [Full Text] [Related]
17. The early and intermediate precursor lesions of tumor progression in the melanocytic system: common acquired nevi and atypical (dysplastic) nevi. Elder DE, Clark WH, Elenitsas R, Guerry D, Halpern AC. Semin Diagn Pathol; 1993 Feb 15; 10(1):18-35. PubMed ID: 8506414 [Abstract] [Full Text] [Related]
18. Important risk factors in melanoma from the Dermato-Oncologic Unit of Brescia, Italy. Manganoni AM, Zanotti F, Farisoglio C, Feroldi P, Facchetti F, Calzavara-Pinton P. Dermatol Online J; 2010 Jan 15; 16(1):17. PubMed ID: 20137759 [Abstract] [Full Text] [Related]
19. [Dysplastic nevus syndrome with familial melanoma (type D2)]. Casanova JM, Panadés MJ, Ramos J, Salvatella N. Med Clin (Barc); 1989 Mar 18; 92(10):382-4. PubMed ID: 2716387 [Abstract] [Full Text] [Related]